批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2014/08/12 |
SUPPL-51(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/04/29 |
SUPPL-50(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2004/05/04 |
SUPPL-46(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/02/28 |
SUPPL-42(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/12/29 |
SUPPL-41(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/04/22 |
SUPPL-40(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1990/12/11 |
SUPPL-38(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1988/12/02 |
SUPPL-37(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1987/01/22 |
SUPPL-36(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1987/01/07 |
SUPPL-35(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1986/01/03 |
SUPPL-34(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1983/06/20 |
SUPPL-32(补充) |
Approval |
Labeling |
|
|
|
1982/12/16 |
SUPPL-33(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1982/09/03 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1982/01/22 |
SUPPL-28(补充) |
Approval |
Labeling |
|
|
|
1981/09/29 |
SUPPL-29(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1981/06/10 |
SUPPL-27(补充) |
Approval |
Labeling |
|
|
|
1980/05/23 |
SUPPL-25(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1980/05/23 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1980/05/01 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1980/01/03 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1979/09/17 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1976/03/11 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1959/06/10 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:METHOCARBAMOL 剂型/给药途径:SOLUTION;IM-IV 规格:1GM/10ML (100MG/ML) 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
011790 |
001 |
NDA |
ROBAXIN |
METHOCARBAMOL |
SOLUTION;IM-IV |
1GM/10ML (100MG/ML) |
Prescription |
Yes |
Yes |
AP |
Approved Prior to Jan 1, 1982
|
HIKMA |
204404 |
001 |
ANDA |
METHOCARBAMOL |
METHOCARBAMOL |
SOLUTION;IM-IV |
1GM/10ML (100MG/ML) |
Discontinued |
No |
No |
AP |
2014/12/05
|
NORVIUM BIOSCIENCE |
206128 |
001 |
ANDA |
METHOCARBAMOL |
METHOCARBAMOL |
SOLUTION;IM-IV |
1GM/10ML (100MG/ML) |
Prescription |
No |
No |
AP |
2016/05/27
|
EUGIA PHARMA |
205354 |
001 |
ANDA |
METHOCARBAMOL |
METHOCARBAMOL |
SOLUTION;IM-IV |
1GM/10ML (100MG/ML) |
Prescription |
No |
No |
AP |
2016/10/27
|
MONTEREY PHARMS LLC |
208116 |
001 |
ANDA |
METHOCARBAMOL |
METHOCARBAMOL |
SOLUTION;IM-IV |
1GM/10ML (100MG/ML) |
Prescription |
No |
No |
AP |
2017/01/19
|
SLATE RUN PHARMA |
207496 |
001 |
ANDA |
METHOCARBAMOL |
METHOCARBAMOL |
SOLUTION;IM-IV |
1GM/10ML (100MG/ML) |
Prescription |
No |
No |
AP |
2017/06/22
|
AM REGENT |
205404 |
001 |
ANDA |
METHOCARBAMOL |
METHOCARBAMOL |
SOLUTION;IM-IV |
1GM/10ML (100MG/ML) |
Prescription |
No |
No |
AP |
2017/07/18
|
SAGENT PHARMS INC |
207522 |
001 |
ANDA |
METHOCARBAMOL |
METHOCARBAMOL |
SOLUTION;IM-IV |
1GM/10ML (100MG/ML) |
Prescription |
No |
No |
AP |
2017/07/31
|
SOMERSET THERAPS LLC |
206071 |
001 |
ANDA |
METHOCARBAMOL |
METHOCARBAMOL |
SOLUTION;IM-IV |
1GM/10ML (100MG/ML) |
Discontinued |
No |
No |
AP |
2017/11/24
|
NAVINTA LLC |
209331 |
001 |
ANDA |
METHOCARBAMOL |
METHOCARBAMOL |
SOLUTION;IM-IV |
1GM/10ML (100MG/ML) |
Prescription |
No |
No |
AP |
2018/04/17
|
FRESENIUS KABI USA |
211504 |
001 |
ANDA |
METHOCARBAMOL |
METHOCARBAMOL |
SOLUTION;IM-IV |
1GM/10ML (100MG/ML) |
Prescription |
No |
No |
AP |
2018/10/26
|
GLAND PHARMA LTD |
215065 |
001 |
ANDA |
METHOCARBAMOL |
METHOCARBAMOL |
SOLUTION;IM-IV |
1GM/10ML (100MG/ML) |
Discontinued |
No |
No |
AP |
2022/07/14
|
BAXTER HLTHCARE CORP |